retatrutide weight loss trial results clinical data Eli Lilly's Phase 3 Results: 28.7% retatrutide trial results news Eli

In this study, we first investigated the effects of GLP-1 on preventing dysfuction and autophagy in endothelial cells induced through oxidative stress

The US leads the way when it comes to the use of these weight loss drugs, even though Ozempic is technically only approved as a treatment to treat people with type 2 diabetes

These findings are from cell studies and haven't been confirmed in a large human clinical trial, but the mechanistic logic is consistent

The Risks In the use of the SGLT-2s, the sugar doesn't need to be necessarily high, says Trence

Why High-Purity BPC-157 Matters When studying subtle biological mechanisms, peptide quality is critical